On May 19, Chong Kun Dang signed an MOU for joint research on new drugs with ENCell, a company that develops cell/gene therapy and next-generation ...
https://www.google.com/url?rct=j&sa=t&url=http://www.koreaittimes.com/news/articleView.html%3Fidxno%3D113055&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw0KLRJORWFFrXJHxeLSZmhR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.